Tygh Capital Management’s Cardlytics CDLX Stock Holding History

Tygh Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,143	Closed	-$3.48M	–	89
2021 Q3	$3.48M	Sell	4,143 -1,993	-32%	-$2.02M	0.47%	76
2021 Q2	$7.79M	Buy	6,136 +2,022	+49%	+$2.28M	1.06%	43
2021 Q1	$4.51M	Buy	4,114 +2,184	+113%	+$2.88M	0.64%	68
2020 Q4	$2.76M	Sell	1,930 -6,270	-76%	-$6.69M	0.43%	81
2020 Q3	$5.79M	Buy	8,200 +1,249	+18%	+$908K	1.1%	43
2020 Q2	$4.86M	Buy	+6,951	New	+$4.01M	1.01%	44
2019 Q4	–	Sell	-12,150	Closed	-$4.07M	–	77
2019 Q3	$4.07M	Sell	12,150 -5,474	-31%	-$1.75M	0.72%	61
2019 Q2	$4.58M	Buy	17,624 +2,579	+17%	+$516K	0.78%	62
2019 Q1	$2.49M	Buy	+15,045	New	+$2.45M	0.44%	74

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Tygh Capital Management's CDLX Position: Q4 2021 in Review

Tygh Capital Management sold out of Cardlytics (CDLX) in Q4 2021, closing a stake of 4,143 shares — an estimated $3.48M sold.

Tygh Capital Management first reported a position in CDLX in Q1 2019 and held it in 9 quarters. The position peaked at $7.79M in Q2 2021. 163 funds tracked by Wall St. Rank hold CDLX as of Q4 2021.

Tygh Capital Management reported no remaining Cardlytics position as of Q4 2021 after selling out during the quarter.
Tygh Capital Management sold 4,143 Cardlytics shares in Q4 2021, an estimated $3.48M.
Tygh Capital Management first reported a position in Cardlytics in Q1 2019 and held it in 9 quarters.
Tygh Capital Management's Cardlytics position peaked at $7.79M in Q2 2021.
163 funds tracked by Wall St. Rank held Cardlytics as of Q4 2021.

Based on Tygh Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.